Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Redhill Biophrma ADR (RDHL)

Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Redhill Biophrma ADR 21 Ha'arba'a Street Tel Aviv L3 64739 ISR

www.redhillbio.com P: 972-3541-3131 F: 972-354-1314

Description:

RedHill Biopharma Ltd. is a specialty biopharmaceutical company, focused on gastrointestinal and infectious diseases. It operates through the Commercial Operations segment and the Research & Development segment. The Commercial Operations segment is based in Raleigh, NC, and covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded in 2009 and is headquartered in Tel Aviv, Israel.

Key Statistics

Overview:

Market Capitalization, $K 12,707
Enterprise Value, $K 6,347
Shares Outstanding, K 29,703
Annual Sales, $ 6,530 K
Annual Net Income, $ 23,920 K
Last Quarter Sales, $ 1,800 K
Last Quarter Net Income, $ 101,240 K
EBIT, $ 8,630 K
EBITDA, $ 14,620 K
60-Month Beta 3.45
% of Insider Shareholders 6.81%
% of Institutional Shareholders 7.20%
Float, K 27,680
% Float 93.19%
Short Volume Ratio 0.53

Growth:

1-Year Return -84.27%
3-Year Return -99.85%
5-Year Return -99.86%
5-Year Revenue Growth -21.89%
5-Year Earnings Growth 105.43%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 36.00 on 08/17/23
Latest Earnings Date 06/10/24
Earnings Per Share ttm 19.47
EPS Growth vs. Prev Qtr 513.29%
EPS Growth vs. Prev Year 550.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 03/23/23

RDHL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 366.31%
Debt/Equity 0.00
Price/Sales 2.01
Price/Cash Flow 0.34
Price/Book 4.30
Book Value/Share 0.11
Interest Coverage 3.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar